Maternal Plasma Micro-RNAs in Fetal Congenital Diaphragmatic Hernia: A Potential Non-Invasive Tool for Prenatal Diagnosis and Risk Stratification
Topic overview
This study investigates maternal plasma microRNAs as a non-invasive biomarker for detecting and stratifying severity of fetal congenital diaphragmatic hernia (CDH). Building on evidence from other prenatal conditions, researchers explore whether unique miRNA profiles in maternal blood can improve upon current imaging-based risk assessment methods for CDH.
Key takeaways
- CDH severity prediction remains limited with current imaging modalities alone
- Distinct miRNA profiles exist in maternal plasma for other prenatal conditions like TTTS
- Amniotic fluid miRNA shows differential expression in severe CDH cases
- Maternal plasma miRNA may offer non-invasive CDH diagnosis and risk stratification
- Unique miRNA signatures could correlate with both CDH presence and disease severity
Keywords
Hashtags
Full article text
Full article text not available for this entry
How to cite: GlobalCastMD. Maternal Plasma Micro-RNAs in Fetal Congenital Diaphragmatic Hernia: A Potential Non-Invasive Tool for Prenatal Diagnosis and Risk Stratification. GlobalCastMD Medical Library. 2025-07-24. https://dev.library.globalcastmd.com/article/10720?via_space=staycurrentmd
Comments